Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells

被引:156
作者
Deplancke, B
Gaskins, HR
机构
[1] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA
[3] Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA
关键词
IEC-18; colorectal cancer; ulcerative colitis; epithelial hyperproliferation; microarray analysis;
D O I
10.1096/fj.02-0883fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen sulfide (H2S), produced by commensal sulfate-reducing bacteria, is an environmental insult that potentially contributes to chronic intestinal epithelial disorders. We tested the hypothesis that exposure of nontransformed intestinal epithelial cells (IEC-18) to the reducing agent sodium hydrogen sulfide (NaHS) activates molecular pathways that underlie epithelial hyperplasia, a phenotype common to both ulcerative colitis (UC) and colorectal cancer. Exposure of IEC-18 cells to NaHS rapidly increased the NADPH/NADP ratio, reduced the intracellular redox environment, and inhibited mitochondrial respiratory activity. The addition of 0.2-5 mM NaHS for 4 h increased the IEC-18 proliferative cell fraction (P<0.05), as evidenced by analysis of the cell cycle and proliferating cell nuclear antigen expression, while apoptosis occurred only at the highest concentration of NaHS. Thirty minutes of NaHS exposure increased (P<0.05) c-Jun mRNA concentrations, consistent with the observed activation of mitogen activated protein kinases (MAPK). Microarray analysis confirmed an increase (P<0.05) in MAPK-mediated proliferative activity, likely reflecting the reduced redox environment of NaHS-treated cells. These data identify functional pathways by which H2S may initiate epithelial dysregulation and thereby contribute to UC or colorectal cancer. Thus, it becomes crucial to understand how genetic background may affect epithelial responsiveness to this bacterial-derived environmental insult.
引用
收藏
页码:1310 / +
页数:29
相关论文
共 78 条
[1]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[2]  
[Anonymous], GUT
[3]   REGULATION OF C-JUN EXPRESSION DURING HYPOXIC AND LOW-GLUCOSE STRESS [J].
AUSSERER, WA ;
BOURRATFLOECK, B ;
GREEN, CJ ;
LADEROUTE, KR ;
SUTHERLAND, RM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) :5032-5042
[4]   Sulfides impair short chain fatty acid β-oxidation at acyl-CoA dehydrogenase level in colonocytes:: Implications for ulcerative colitis [J].
Babidge, W ;
Millard, S ;
Roediger, W .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 181 (1-2) :117-124
[5]   The IGF-I receptor and cancer [J].
Baserga, R ;
Resnicoff, M ;
Dews, M .
ENDOCRINE, 1997, 7 (01) :99-102
[6]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[7]  
BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710
[8]  
CHRISTL SU, 1995, Z GASTROENTEROL, V33, P408
[9]   Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa - A potential role for these agents in the pathogenesis of ulcerative colitis [J].
Christl, SU ;
Eisner, HD ;
Dusel, G ;
Kasper, H ;
Scheppach, W .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) :2477-2481
[10]   The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis [J].
Chung, DC .
GASTROENTEROLOGY, 2000, 119 (03) :854-865